We are live on ! Find out more
PCM

Patient Capital Management Portfolio holdings

AUM $2.74B
1-Year Est. Return 43.59%
This Fund
S&P 500
This Quarter Est. Return
+4.05%
1 Year Est. Return
+43.59%
3 Year Est. Return
+124.98%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$206M
AUM Growth
+$5.56M
Cap. Flow
+$5.34M
Cap. Flow %
2.59%
Top 10 Hldgs %
41.54%
Holding
45
New
3
Increased
11
Reduced
15
Closed
2

Top Buys

Rank Stock Value
1
SI
Silvergate Capital Corporation
SI
+$5.38M
2
GOOS
Canada Goose Holdings
GOOS
+$3.5M
3
FTCH
Farfetch Limited Class A Ordinary Shares
FTCH
+$2.22M
4
EXE
Expand Energy Corp
EXE
+$1.59M
5
PTON icon
Peloton Interactive
PTON
+$959K

Top Sells

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$2.99M
2
FANG icon
Diamondback Energy
FANG
+$2.34M
3
CLF icon
Cleveland-Cliffs
CLF
+$1.32M
4
BHC icon
Bausch Health
BHC
+$1.29M
5
ADT icon
ADT
ADT
+$942K

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 32.4%
2 Financials 17.44%
3 Energy 13.02%
4 Technology 10.53%
5 Industrials 10.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OVV icon
1
Ovintiv
OVV
$16.6B
$12.7M 6.16%
250,400
-7,500
-3% -$392K
EXPE icon
2
Expedia Group
EXPE
$37.3B
$11.6M 5.62%
132,025
+5,825
+5% +$551K
OMF icon
3
OneMain Financial
OMF
$7.43B
$9.29M 4.51%
278,900
– –
ET icon
4
Energy Transfer Partners
ET
$70B
$8.78M 4.26%
739,800
-21,600
-3% -$259K
BABA icon
5
Alibaba
BABA
$307B
$7.78M 3.78%
88,375
-3,675
-4% -$290K
TEVA icon
6
Teva Pharmaceuticals
TEVA
$41.1B
$7.59M 3.69%
832,575
-342,425
-29% -$2.99M
MAT icon
7
Mattel
MAT
$4.2B
$7.59M 3.69%
425,500
-7,800
-2% -$141K
DAL icon
8
Delta Air Lines
DAL
$60.1B
$6.91M 3.36%
210,300
– –
AMZN icon
9
Amazon
AMZN
$3T
$6.69M 3.25%
79,700
– –
FISV
10
Fiserv Inc
FISV
$27.7B
$6.66M 3.23%
65,900
-8,800
-12% -$876K
GOOS
11
Canada Goose Holdings
GOOS
$862M
$6.66M 3.23%
373,700
+199,800
+115% +$3.5M
GOOGL icon
12
Alphabet (Google) Class A
GOOGL
$4.36T
$6.28M 3.05%
71,200
– –
NCLH icon
13
Norwegian Cruise Line
NCLH
$8.83B
$6.16M 2.99%
503,100
+37,850
+8% +$570K
GM icon
14
General Motors
GM
$76.8B
$6.15M 2.98%
182,700
-5,000
-3% -$185K
C icon
15
Citigroup
C
$226B
$6.14M 2.98%
135,800
– –
JPM icon
16
JPMorgan Chase
JPM
$948B
$6.1M 2.96%
45,500
+1,050
+2% +$133K
TMHC
17
DELISTED
Taylor Morrison
TMHC
$5.72M 2.78%
188,600
– –
UBER icon
18
Uber
UBER
$153B
$5.45M 2.64%
220,200
-9,700
-4% -$265K
UAL icon
19
United Airlines
UAL
$41.7B
$5.27M 2.56%
139,800
– –
FTCH
20
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
$5.11M 2.48%
1,081,100
+318,100
+42% +$2.22M
META icon
21
Meta Platforms (Facebook)
META
$1.52T
$4.83M 2.35%
40,175
+1,645
+4% +$193K
TNL icon
22
Travel + Leisure Co
TNL
$4.69B
$4.63M 2.25%
127,300
+10,100
+9% +$378K
SPLK
23
DELISTED
Splunk Inc
SPLK
$4.56M 2.22%
53,000
+5,425
+11% +$438K
CLF icon
24
Cleveland-Cliffs
CLF
$6.93B
$4.5M 2.19%
279,600
-87,600
-24% -$1.32M
DXC icon
25
DXC Technology
DXC
$1.74B
$4.26M 2.07%
160,600
-29,400
-15% -$818K
1
2

Similar funds

CIAS
CBIZ Investment Advisory Services Independence, Ohio $2.74B AUM 14.19% 1-Year Est. Return
LMIM
Lockheed Martin Investment Management Bethesda, Maryland $2.73B AUM 28.24% 1-Year Est. Return
GC
Giverny Capital Montreal, Quebec, Canada $2.73B AUM 14.09% 1-Year Est. Return
CC
Cartenna Capital Stamford, Connecticut $2.74B AUM 44.46% 1-Year Est. Return
PA
Profund Advisors Bethesda, Maryland $2.72B AUM 47.27% 1-Year Est. Return
XL
XN LP New York $2.72B AUM 46.67% 1-Year Est. Return
SFFS
Stonehage Fleming Financial Services St. Helier, Jersey $2.75B AUM 13.81% 1-Year Est. Return
HRCM
Hawk Ridge Capital Management Los Angeles, California $2.75B AUM 20.09% 1-Year Est. Return

Patient Capital Management's Q4 2022 Portfolio in Review

As of Q4 2022, Patient Capital Management held 45 positions worth $206M, up 2.8% from $200M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Patient Capital Management's Q4 2022 filing shows 3 new, 11 increased, 15 reduced and 2 closed positions. Its largest new stake was Silvergate Capital Corporation: 135,600 shares worth $2.36M. The largest sale was Teva Pharmaceuticals, an estimated $2.99M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 32% of assets, up from 31% a quarter earlier, followed by Financials and Energy.

  • Patient Capital Management's largest Q4 2022 buy was Silvergate Capital Corporation: 135,600 shares worth $2.36M.
  • Patient Capital Management added most to Canada Goose Holdings in Q4 2022, an estimated $3.5M increase.
  • Patient Capital Management's biggest Q4 2022 reduction was Teva Pharmaceuticals, cutting an estimated $2.99M.
  • Patient Capital Management fully exited Bausch Health in Q4 2022, selling an estimated $1.29M.
  • Patient Capital Management's ten largest holdings make up 42% of its $206M portfolio in Q4 2022.
  • Patient Capital Management opened 3 new positions and closed 2 in Q4 2022.
  • Patient Capital Management's portfolio value rose 2.8% quarter-over-quarter to $206M.

Based on Patient Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.